Opinion: ‘Pink tape’ at the FDA is delaying access to contraception — again
As the crisis over access to reproductive health deepens in the U.S., the Food and Drug Administration (FDA) has been quietly working with two pharmaceutical companies pursuing a historic breakthrough in expanding access to contraception: eliminating the unnecessary barrier of a prescription for the birth control pill, and allowing people to purchase it directly.
The safety and effectiveness of the pill has been well established during its 62 years on the market. That means the FDA has to decide only two things to move forward with making it an over-the-counter product: Can women understand the label on the packaging, and can they be trusted to follow the label instructions to determine whether these products are right for them?
Read Original Article: Opinion: ‘Pink tape’ at the FDA is delaying access to contraception — again »
